FDA Inspection
Allergan Sales, LLCAllergan Sales, LLC – FDA Inspection, Jul 28, 2023
Record Details
This FDA Inspection record concerns Allergan Sales, LLC, with an inspection on July 28, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Carrie A. Hughes (Issuing Officer)
- Mariza M. Jafary (Issuing Officer)
- Nicholas L. Hunt (FDA Associated Person)
View Company Profile
ID · f8db6235-cab5-4ddf-b46d-a4932de3ec7f
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1217963
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Allergan Sales, LLC
14| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2025 | Not classified | Los Angeles District Office | |
| September 19, 2025 | Not classified | Los Angeles District Office | |
| October 26, 2023 | Not classified | Los Angeles District Office | |
| January 22, 2019 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| October 19, 2016 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Allergan Sales, LLC
- FDA Inspection 1285134 - 2025-11-07
- FDA Inspection 1276207 - 2025-09-19
- FDA Inspection 1226167 - 2023-10-26
- FDA Inspection 1077891 - 2019-01-22
- FDA Inspection 991910 - 2016-10-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.